Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of high-dose fluconazole on QT interval in patients with human immunodeficiency virus (HIV)-associated cryptococcal meningitis.
Manosuthi W, Sungkanuparph S, Anekthananon T, Supparatpinyo K, Nolen TL, Zimmer LO, Pappas PG, Larsen RA, Filler SG, Chetchotisakd P; BAMSG 3-01 Study Team. Manosuthi W, et al. Int J Antimicrob Agents. 2009 Nov;34(5):494-6. doi: 10.1016/j.ijantimicag.2009.05.009. Epub 2009 Jun 30. Int J Antimicrob Agents. 2009. PMID: 19570657 Free PMC article. No abstract available.
A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis.
Pappas PG, Chetchotisakd P, Larsen RA, Manosuthi W, Morris MI, Anekthananon T, Sungkanuparph S, Supparatpinyo K, Nolen TL, Zimmer LO, Kendrick AS, Johnson P, Sobel JD, Filler SG. Pappas PG, et al. Among authors: manosuthi w. Clin Infect Dis. 2009 Jun 15;48(12):1775-83. doi: 10.1086/599112. Clin Infect Dis. 2009. PMID: 19441980 Clinical Trial.
Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study.
Sungkanuparph S, Filler SG, Chetchotisakd P, Pappas PG, Nolen TL, Manosuthi W, Anekthananon T, Morris MI, Supparatpinyo K, Kopetskie H, Kendrick AS, Johnson PC, Sobel JD, Larsen RA. Sungkanuparph S, et al. Among authors: manosuthi w. Clin Infect Dis. 2009 Sep 15;49(6):931-4. doi: 10.1086/605497. Clin Infect Dis. 2009. PMID: 19681708
Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients.
Manosuthi W, Chetchotisakd P, Nolen TL, Wallace D, Sungkanuparph S, Anekthananon T, Supparatpinyo K, Pappas PG, Larsen RA, Filler SG, Andes D; BAMSG 3-01 Study Team. Manosuthi W, et al. HIV Med. 2010 Apr;11(4):276-81. doi: 10.1111/j.1468-1293.2009.00778.x. Epub 2009 Dec 8. HIV Med. 2010. PMID: 20002501 Free PMC article. Clinical Trial.
Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients.
Anekthananon T, Manosuthi W, Chetchotisakd P, Kiertiburanakul S, Supparatpinyo K, Ratanasuwan W, Pappas PG, Filler SG, Kopetskie HA, Nolen TL, Kendrick AS, Larsen RA; BAMSG 3-01 Study Team. Anekthananon T, et al. Among authors: manosuthi w. Int J STD AIDS. 2011 Nov;22(11):665-70. doi: 10.1258/ijsa.2011.010538. Int J STD AIDS. 2011. PMID: 22096053
CYP2B6 haplotype and biological factors responsible for hepatotoxicity in HIV-infected patients receiving efavirenz-based antiretroviral therapy.
Manosuthi W, Sukasem C, Lueangniyomkul A, Mankatitham W, Thongyen S, Nilkamhang S, Manosuthi S, Sungkanuparph S. Manosuthi W, et al. Among authors: manosuthi s. Int J Antimicrob Agents. 2014 Mar;43(3):292-6. doi: 10.1016/j.ijantimicag.2013.10.022. Epub 2013 Nov 25. Int J Antimicrob Agents. 2014. PMID: 24359841
146 results